NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholde
Top insights from the latest market news from Monday, April 27, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Organon (OGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength dow
Stock futures are struggling this morning as investors await Magnificent Seven earnings and the Fed meeting
U.S. stock futures fell on Monday, following Friday's mixed close. Futures of the major benchmark indices were lower. This week, investors will be closely watching the Federal Reserve's meeting to gau
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Organon & Co. (NYSE: OGN) to Sun Pharmaceutical Industries Limited for $14.00 per share.Halper Sa
India's Sun Pharmaceutical Industries agrees to buy the women's health company for $14 a share in an all-cash deal.
MILWAUKEE, April 27, 2026 /PRNewswire/ -- Ademi LLP is investigating Organon (NYSE: OGN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with
Organon and Co. has agreed to be acquired by Sun Pharmaceutical Industries in an all-cash deal valued at $11.75 billion, offering shareholders a 103% premium and marking a major step in Sun Pharma's g
In one of the biggest outbound acquisitions ever attempted by an Indian company, Sun Pharmaceutical Industries has decided to buy Organon & Co. for $14 a share in an all-cash deal valued at $11.8 bill
Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Sun Pharmaceutical will buy all outstanding shares of Organ
Sun Pharma has offered to pay $14.00 a share in an all-cash deal.
Sun Pharmaceutical ​Industries ‌will acquire Organon & ​Co ​in an ⁠all‑cash ​deal, ​valuing the U.S. drugmaker ​at ​about $11.75 billion, ‌the ⁠companies said in a ​joint ​
MUMBAI, India & JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or asso
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE